Aronne, Louis J

Publications

Sort by

Co-Author Network

selected publications

New insights into the treatment of obesity. Diabetes, obesity & metabolism. 2023 Review GET IT
Times cited: 1
Five-year weight loss maintenance with obesity pharmacotherapy. The Journal of clinical endocrinology and metabolism. 2023 Academic Article GET IT
When Weight Impacts Health. The New England journal of medicine. 2023 Academic Article GET IT
Pharmacologic management of weight regain following bariatric surgery. Frontiers in endocrinology. 2023 Academic Article GET IT
Times cited: 15
Weight and Health - Pathophysiology and Therapies. The New England journal of medicine. 2022 Academic Article GET IT
Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program. Obesity (Silver Spring, Md.). 2022 Academic Article GET IT
Times cited: 3
Tirzepatide Once Weekly for the Treatment of Obesity. Reply. The New England journal of medicine. 2022 Letter GET IT
Times cited: 2
Impact of refitted race-free eGFR formula on obesity pharmacotherapy options. Obesity (Silver Spring, Md.). 2022 Academic Article GET IT
Times cited: 1
Management of Weight Regain Following Bariatric Surgery: Behavioral Intervention and Pharmacotherapy. Expert review of endocrinology & metabolism. 2022 Academic Article GET IT
Competing paradigms of obesity pathogenesis: energy balance versus carbohydrate-insulin models. European journal of clinical nutrition. 2022 Review GET IT
Times cited: 16
Tirzepatide Once Weekly for the Treatment of Obesity. The New England journal of medicine. 2022 Academic Article GET IT
Times cited: 294
Medical weight management protects against weight gain during the COVID-19 pandemic. Obesity science & practice. 2022 Academic Article GET IT
Times cited: 81
Weight Loss Outcomes With Telemedicine During COVID-19. Frontiers in endocrinology. 2022 Academic Article GET IT
Times cited: 99
Telemedicine could be the solution to scaling obesity treatment. Obesity (Silver Spring, Md.). 2022 Comment GET IT
Reply to A Drewnowski et al, O Devinsky, D A Booth and E L Gibson, and D J Millward. The American journal of clinical nutrition. 2022 Letter GET IT
Recent advances in therapies utilizing superabsorbent hydrogel technology for weight management: A review. Obesity science & practice. 2021 Review GET IT
Long-term weight loss maintenance with obesity pharmacotherapy: A retrospective cohort study. Obesity science & practice. 2021 Academic Article GET IT
Times cited: 2
The carbohydrate-insulin model: a physiological perspective on the obesity pandemic. The American journal of clinical nutrition. 2021 Academic Article GET IT
Times cited: 96
Understanding the pathophysiologic pathways that underlie obesity and options for treatment. Expert review of endocrinology & metabolism. 2021 Review GET IT
Times cited: 3
Impact of Adjunctive Pharmacotherapy With Intragastric Balloons for the Treatment of Obesity. The American surgeon. 2021 Academic Article GET IT
Times cited: 2
Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit. Frontiers in endocrinology. 2021 Review GET IT
Times cited: 49
Word selection and weight bias. Obesity (Silver Spring, Md.). 2021 Letter GET IT
Times cited: 1
Preadmission predictors of severe COVID-19 in patients with diabetes mellitus. Journal of diabetes and its complications. 2021 Academic Article GET IT
Times cited: 4
Impact of Telemedicine During the COVID-19 Pandemic on Patient Attendance. Obesity (Silver Spring, Md.). 2021 Letter GET IT
Times cited: 6
The Independent Risk of Obesity and Diabetes and Their Interaction in COVID-19: A Retrospective Cohort Study. Obesity (Silver Spring, Md.). 2021 Academic Article GET IT
Times cited: 11
Describing the Weight-Reduced State: Physiology, Behavior, and Interventions. Obesity (Silver Spring, Md.). 2021 Conference Paper GET IT
Times cited: 24
Return on Investment: Medical Savings of an Employer-Sponsored Digital Intensive Lifestyle Intervention, Weight Loss. Obesity (Silver Spring, Md.). 2021 Academic Article GET IT
Times cited: 2
Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity. Journal of medical virology. 2021 Academic Article GET IT
Times cited: 27
Use of Weight Loss Medications in Patients after Bariatric Surgery. Current obesity reports. 2021 Review GET IT
Times cited: 10
Metformin-induced weight loss in patients with or without type 2 diabetes/prediabetes: A retrospective cohort study. Obesity research & clinical practice. 2020 Academic Article GET IT
Times cited: 7
Effect of an Online Weight Management Program Integrated With Population Health Management on Weight Change: A Randomized Clinical Trial. JAMA. 2020 Academic Article GET IT
Times cited: 15
Five-Year Outcomes of Endoscopic Sleeve Gastroplasty for the Treatment of Obesity. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2020 Academic Article GET IT
Times cited: 40
Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty. Gastrointestinal endoscopy. 2020 Academic Article GET IT
Times cited: 31
Medical Weight-Loss Outcomes in Patients Receiving Concomitant Psychotropic Medication: A Retrospective Cohort Study. Obesity (Silver Spring, Md.). 2020 Academic Article GET IT
Times cited: 2
Iatrogenic Obesity. Endocrinology and metabolism clinics of North America. 2020 Review GET IT
Times cited: 1
Integrating an online weight management program with population health management in primary care: Design, methods, and baseline data from the PROPS randomized controlled trial (Partnerships for Reducing Overweight and Obesity with Patient-centered Strategies). Contemporary clinical trials. 2020 Academic Article GET IT
Times cited: 4
Joint international consensus statement for ending stigma of obesity. Nature medicine. 2020 Review GET IT
Times cited: 342
Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes. International journal of obesity (2005). 2020 Academic Article GET IT
Times cited: 6
Utility of BMIQ, a novel web-based weight management programme, at an academic weight management centre. Obesity science & practice. 2019 Academic Article GET IT
Times cited: 3
Efficacy of Endoscopic Interventions for the Management of Obesity: a Meta-analysis to Compare Endoscopic Sleeve Gastroplasty, AspireAssist, and Primary Obesity Surgery Endolumenal. Obesity surgery. 2019 Review GET IT
Times cited: 27
Erratum: A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss. Obesity (Silver Spring, Md.). 2019 Article GET IT
Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2019 Academic Article GET IT
Times cited: 30
It's Time for Multidisciplinary Obesity Management Centers. Obesity (Silver Spring, Md.). 2019 Comment GET IT
Times cited: 1
Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options. Expert opinion on pharmacotherapy. 2019 Review GET IT
Times cited: 7
Weight Loss Medications in Older Adults After Bariatric Surgery for Weight Regain or Inadequate Weight Loss: A Multicenter Study. Bariatric surgical practice and patient care. 2018 Academic Article GET IT
Times cited: 13
A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss. Obesity (Silver Spring, Md.). 2018 Academic Article GET IT
Times cited: 69
Obesity: When to consider surgery. 2018 GET IT
Times cited: 4
Implementing an Online Weight-Management Intervention to an Employee Population: Initial Experience with Real Appeal. Obesity (Silver Spring, Md.). 2018 Academic Article GET IT
Times cited: 8
Resistance Training Reduces Skeletal Muscle Work Efficiency in Weight-Reduced and Non-Weight-Reduced Subjects. Obesity (Silver Spring, Md.). 2018 Academic Article GET IT
Times cited: 10
The impact of food order on postprandial glycaemic excursions in prediabetes. Diabetes, obesity & metabolism. 2018 Academic Article GET IT
Times cited: 34
Weight Loss Medications in Young Adults after Bariatric Surgery for Weight Regain or Inadequate Weight Loss: A Multi-Center Study. Children (Basel, Switzerland). 2018 Academic Article GET IT
Times cited: 178
Setting Up An Endobariatric Weight Loss Program. The American journal of gastroenterology. 2018 Academic Article GET IT
Times cited: 1
Devices and Endoscopic Bariatric Therapies for Obesity. Current obesity reports. 2018 Review GET IT
Times cited: 14
Intestinal and Gastric Origins for Diabetes Resolution After Bariatric Surgery. Current obesity reports. 2018 Review GET IT
Times cited: 9
ADOPT: Obesity Treatment Reaches Level of Maturity with Its Own Collaborative Initiative and Resource. Obesity (Silver Spring, Md.). 2018 Editorial Article GET IT
Times cited: 2
The challenge of meeting prescribed carbohydrate intake goals in low-carbohydrate diet studies. The American journal of clinical nutrition. 2018 Letter GET IT
Times cited: 2
Current concepts in management of weight regain following bariatric surgery. Expert review of endocrinology & metabolism. 2018 Review GET IT
Times cited: 30
Effect of Food Order on Ghrelin Suppression. Diabetes care. 2018 Letter GET IT
Times cited: 9
Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-World Population. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2018 Academic Article GET IT
Times cited: 49
Effect of Lorcaserin Alone and in Combination with Phentermine on Food Cravings After 12-Week Treatment: A Randomized Substudy. Obesity (Silver Spring, Md.). 2018 Academic Article GET IT
Times cited: 9
Pharmacotherapy for obesity in individuals with type 2 diabetes. Expert opinion on pharmacotherapy. 2018 Review GET IT
Times cited: 11
Obesity Pharmacotherapy. The Medical clinics of North America. 2018 Review GET IT
Times cited: 85
Endoscopic Sleeve Gastroplasty, Laparoscopic Sleeve Gastrectomy, and Laparoscopic Band for Weight Loss: How Do They Compare?. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2017 Academic Article GET IT
Times cited: 66
Liraglutide and cardiovascular outcomes in adults with overweight or obesity: A post hoc analysis from SCALE randomized controlled trials. Diabetes, obesity & metabolism. 2017 Review GET IT
Times cited: 50
Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up. Obesity surgery. 2017 Academic Article GET IT
Times cited: 146
Obesity: When to consider medication. The Journal of family practice. 2017 Review GET IT
Times cited: 6
Carbohydrate-last meal pattern lowers postprandial glucose and insulin excursions in type 2 diabetes. BMJ open diabetes research & care. 2017 Academic Article GET IT
Times cited: 38
A single-operator learning curve analysis for the endoscopic sleeve gastroplasty. Gastrointestinal endoscopy. 2017 Academic Article GET IT
Times cited: 53
Is Obesity the New Hypertension? Parallels in the Evolution of Obesity and Hypertension as Recognized Disease States. Current atherosclerosis reports. 2017 Review GET IT
Times cited: 4
The American Board of Obesity Medicine: Five-year report. Obesity (Silver Spring, Md.). 2017 Academic Article GET IT
Times cited: 21
Bariatric Surgery or Intensive Medical Therapy for Diabetes after 5 Years. The New England journal of medicine. 2017 Letter GET IT
Coadministration of lorcaserin and phentermine for weight management: A 12-week, randomized, pilot safety study. Obesity (Silver Spring, Md.). 2017 Academic Article GET IT
Times cited: 30
Current and Future Medical Treatment of Obesity. Gastrointestinal endoscopy clinics of North America. 2017 Review GET IT
Times cited: 5
Pharmacotherapy for Weight Management in the VHA. Journal of general internal medicine. 2017 Academic Article GET IT
Times cited: 16
Use of lorcaserin for glycemic control in patients with type 2 diabetes mellitus. Obesity (Silver Spring, Md.). 2017 Comment GET IT
Times cited: 1
White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education, and Resources. 2017 GET IT
Times cited: 84
Practical Use of Pharmacotherapy for Obesity. Gastroenterology. 2017 Review GET IT
Times cited: 41
Obesity Coverage on Medical Licensing Examinations in the United States. What Is Being Tested?. Teaching and learning in medicine. 2016 Academic Article GET IT
Times cited: 25
Endoscopic Sleeve Gastroplasty Significantly Reduces Body Mass Index and Metabolic Complications in Obese Patients. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2016 Academic Article GET IT
Times cited: 140
Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial. The American journal of gastroenterology. 2016 Academic Article GET IT
Times cited: 112
Drug-induced weight gain: Rethinking our choices. The Journal of family practice. 2016 Review GET IT
Times cited: 14
The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2016 Academic Article GET IT
Times cited: 104
An update on naltrexone/bupropion extended-release in the treatment of obesity. Expert opinion on pharmacotherapy. 2016 Academic Article GET IT
Times cited: 12
Trimming the fat: endoscopic suturing for tightening of prior endoscopic sleeve gastroplasty. 2016 GET IT
Times cited: 7
Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s. Obesity (Silver Spring, Md.). 2016 Academic Article GET IT
Times cited: 74
Pharmacotherapy for Obesity. Endocrinology and metabolism clinics of North America. 2016 Review GET IT
Times cited: 29
Pharmacologic Approaches to Weight Management: Recent Gains and Shortfalls in Combating Obesity. Current atherosclerosis reports. 2016 Review GET IT
Times cited: 11
Metformin: an Old Therapy that Deserves a New Indication for the Treatment of Obesity. Current atherosclerosis reports. 2016 Review GET IT
Times cited: 34
Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. International journal of obesity (2005). 2016 Academic Article GET IT
Times cited: 205
Response to Comment on Shukla et al. Food Order Has a Significant Impact on Postprandial Glucose and Insulin Levels. Diabetes Care 2015;38:e98-e99. Diabetes care. 2015 Letter GET IT
Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity. Expert review of clinical pharmacology. 2015 Review GET IT
Times cited: 12
The 2013 American Heart Association/American College of Cardiology/The Obesity Society Guideline for the Management of Overweight and Obesity in Adults: What Is New About Diet, Drugs, and Surgery for Obesity? 2015 GET IT
Times cited: 17
Lorcaserin Hcl for the treatment of obesity. Expert opinion on pharmacotherapy. 2015 Review GET IT
Times cited: 23
Food Order Has a Significant Impact on Postprandial Glucose and Insulin Levels. Diabetes care. 2015 Letter GET IT
Times cited: 55
Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives. Expert opinion on biological therapy. 2015 Review GET IT
Times cited: 16
Efficacy comparison of medications approved for chronic weight management. Obesity (Silver Spring, Md.). 2015 Review GET IT
Times cited: 24
Pharmacological management of obesity: an endocrine Society clinical practice guideline. 2015 GET IT
Times cited: 731
Treatment of obesity in 2015. Journal of cardiopulmonary rehabilitation and prevention. 2015 Review GET IT
Times cited: 34
Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy. 2014 Academic Article GET IT
Times cited: 80
Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study. International journal of obesity (2005). 2014 Article GET IT
Times cited: 10
Safety and efficacy of lorcaserin: a combined analysis of the BLOOM and BLOSSOM trials. Postgraduate medicine. 2014 Academic Article GET IT
Times cited: 52
Endoscopic sleeve plication for revision of sleeve gastrectomy. 2014 GET IT
Times cited: 8
Evolving directions in obesity management. The Journal of family practice. 2014 Review GET IT
Times cited: 3
Hypothalamic Inflammation: Is There Evidence for Human Obesity?. Current obesity reports. 2014 Academic Article GET IT
Recombinant human leptin does not alter gut hormone levels after gastric bypass but may attenuate sweet cravings. International journal of endocrinology. 2014 Academic Article GET IT
Times cited: 5
Weight loss treatment in obese adults--reply. JAMA. 2013 Letter GET IT
Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults. Obesity (Silver Spring, Md.). 2013 Academic Article GET IT
Times cited: 136
Zonisamide for weight reduction in obese adults. JAMA. 2013 Comment GET IT
Times cited: 6
Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. International journal of obesity (2005). 2013 Academic Article GET IT
Times cited: 460
Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. Journal of clinical lipidology. 2013 Academic Article GET IT
Times cited: 293
A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring, Md.). 2013 Academic Article GET IT
Times cited: 384
Randomized double-blind placebo-controlled study of leptin administration after gastric bypass. Obesity (Silver Spring, Md.). 2013 Academic Article GET IT
Times cited: 41
Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment--a position paper of the The Obesity Society and The American Society of Hypertension. Obesity (Silver Spring, Md.). 2012 Review GET IT
Times cited: 190
Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension. Journal of clinical hypertension (Greenwich, Conn.). 2012 Review GET IT
Times cited: 297
Causes of obesity. Abdominal imaging. 2012 Review GET IT
Times cited: 182
Phentermine plus topiramate for the treatment of obesity. Expert review of endocrinology & metabolism. 2012 Academic Article GET IT
Times cited: 1
Advances in medical therapy for weight loss and the weight-centric management of type 2 diabetes mellitus. Current atherosclerosis reports. 2012 Review GET IT
Times cited: 20
Implantable gastric stimulator does not prevent the increase in plasma ghrelin levels that occurs with weight loss. Obesity (Silver Spring, Md.). 2011 Academic Article GET IT
The combination of phentermine and topiramate is an effective adjunct to diet and lifestyle modification for weight loss and measures of comorbidity in overweight or obese adults with additional metabolic risk factors. Evidence-based medicine. 2011 Comment GET IT
Emerging pharmacotherapy for obesity. Expert opinion on emerging drugs. 2011 Review GET IT
Times cited: 23
New drug targets for the treatment of obesity. Clinical pharmacology and therapeutics. 2011 Review GET IT
Times cited: 97
Efficacy and safety of CP-945,598, a selective cannabinoid CB1 receptor antagonist, on weight loss and maintenance. Obesity (Silver Spring, Md.). 2011 Academic Article GET IT
Times cited: 23
Obesity in 2010: the future of obesity medicine: where do we go from here?. Nature reviews. Endocrinology. 2011 Review GET IT
Times cited: 12
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study. International journal of obesity (2005). 2010 Academic Article GET IT
Times cited: 76
Impact of waist circumference difference on health-care cost among overweight and obese subjects: the PROCEED cohort. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2010 Academic Article GET IT
Times cited: 15
Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial. Obesity (Silver Spring, Md.). 2010 Academic Article GET IT
Times cited: 82
Ten putative contributors to the obesity epidemic. Critical reviews in food science and nutrition. 2009 Review GET IT
Times cited: 510
Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease?. International journal of clinical practice. 2009 Review GET IT
Times cited: 42
The problem of obesity in the United States has become increasingly prominent and is now recognized as a critical target for public health intervention. Introduction. The American journal of medicine. 2009 Article GET IT
Times cited: 1
When prevention fails: obesity treatment strategies. The American journal of medicine. 2009 Review GET IT
Times cited: 35
Obesity as a disease state: a new paradigm for diagnosis and treatment. Clinical cornerstone. 2009 Academic Article GET IT
Times cited: 58
PROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: baseline health and healthcare utilization of the US sample. Diabetes, obesity & metabolism. 2008 Academic Article GET IT
Times cited: 16
Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial. International journal of obesity (2005). 2008 Academic Article GET IT
Times cited: 35
Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity. Diabetes care. 2008 Academic Article GET IT
Times cited: 124
The challenge of treating obesity: the endocannabinoid system as a potential target. Journal of the American Dietetic Association. 2008 Review GET IT
Times cited: 12
Rimonabant: new data and emerging experience. Current atherosclerosis reports. 2008 Review GET IT
Times cited: 11
The endocannabinoid system as a target for obesity treatment. Clinical cornerstone. 2008 Academic Article GET IT
Times cited: 10
Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: efficacy. The American journal of cardiology. 2007 Review GET IT
Times cited: 10
Pharmacotherapy for obesity. Current atherosclerosis reports. 2007 Review GET IT
Times cited: 11
The impact of obesity on cardiometabolic risk. JAAPA : official journal of the American Academy of Physician Assistants. 2007 Academic Article GET IT
Times cited: 1
Cardiovascular disease in obesity: A review of related risk factors and risk-reduction strategies. Journal of clinical lipidology. 2007 Academic Article GET IT
Times cited: 18
Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients. Obesity (Silver Spring, Md.). 2007 Academic Article GET IT
Times cited: 19
Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study. The Journal of clinical endocrinology and metabolism. 2007 Academic Article GET IT
Times cited: 145
New targets for obesity pharmacotherapy. Clinical pharmacology and therapeutics. 2007 Review GET IT
Times cited: 47
Is rimonabant a safe and effective treatment for obesity?. Nature clinical practice. Endocrinology & metabolism. 2007 Comment GET IT
Times cited: 4
Therapeutic options for modifying cardiometabolic risk factors. The American journal of medicine. 2007 Review GET IT
Times cited: 34
Overweight and obesity: key components of cardiometabolic risk. Clinical cornerstone. 2007 Review GET IT
Times cited: 38
Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction. The American journal of cardiology. 2006 Review GET IT
Times cited: 61
Weight-Reduction Counseling in Gastroenterologic and Hepatologic Practice. Gastroenterology & hepatology. 2006 Academic Article GET IT
Putative contributors to the secular increase in obesity: exploring the roads less traveled. International journal of obesity (2005). 2006 Review GET IT
Times cited: 485
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA. 2006 Academic Article GET IT
Times cited: 1125
Medical assessment of obese older patients. Clinics in geriatric medicine. 2005 Review GET IT
Times cited: 5
Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group IV: prevention/treatment. Circulation. 2004 Conference Paper GET IT
Times cited: 28
HCA efficiency. Diabetes, obesity & metabolism. 2004 Letter GET IT
Times cited: 3
Gastric pacing is not enough: additional measures for an effective obesity treatment program. Obesity surgery. 2004 Review GET IT
Times cited: 8
Pharmacological approaches to weight reduction: therapeutic targets. The Journal of clinical endocrinology and metabolism. 2004 Review GET IT
Times cited: 81
Obesity and pharmacologic therapy. Endocrinology and metabolism clinics of North America. 2003 Review GET IT
Times cited: 47
The emerging science of body weight regulation and its impact on obesity treatment. The Journal of clinical investigation. 2003 Academic Article GET IT
Times cited: 108
Weight gain in the treatment of mood disorders. The Journal of clinical psychiatry. 2003 Review GET IT
Times cited: 99
Classification of obesity and assessment of obesity-related health risks. Obesity research. 2002 Review GET IT
Times cited: 194
Managing overweight and obesity in women. Clinical obstetrics and gynecology. 2002 Review GET IT
Times cited: 9
Obesity as a disease: etiology, treatment, and management considerations for the obese patient. Obesity research. 2002 Review GET IT
Times cited: 24
Adiposity and fat distribution outcome measures: assessment and clinical implications. Obesity research. 2002 Review GET IT
Times cited: 72
Obesity surgery: pros and cons. Journal of endocrinological investigation. 2002 Review GET IT
Times cited: 6
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin. Diabetes care. 2002 Academic Article GET IT
Times cited: 214
Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats. Metabolism: clinical and experimental. 2001 Academic Article GET IT
Times cited: 48
Epidemiology, morbidity, and treatment of overweight and obesity. The Journal of clinical psychiatry. 2001 Review GET IT
Times cited: 112
Treating obesity: a new target for prevention of coronary heart disease. Progress in cardiovascular nursing. 2001 Review GET IT
Times cited: 16
The effects of drugs used to treat obesity on the autonomic nervous system. Obesity research. 2000 Academic Article GET IT
Times cited: 29
Orlistat and weight loss. The American journal of clinical nutrition. 2000 Letter GET IT
Times cited: 1
Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasis. Diabetes. 1999 Academic Article GET IT
Times cited: 50
Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. The American journal of clinical nutrition. 1999 Academic Article GET IT
Times cited: 267
Therapeutic controversy: Obesity--a modern-day epidemic. The Journal of clinical endocrinology and metabolism. 1999 Academic Article GET IT
Times cited: 59
Modern medical management of obesity: the role of pharmaceutical intervention. Journal of the American Dietetic Association. 1998 Review GET IT
Times cited: 33
Obesity. The Medical clinics of North America. 1998 Review GET IT
Times cited: 31
Exonic and intronic sequence variation in the human leptin receptor gene (LEPR). Diabetes. 1997 Academic Article GET IT
Times cited: 95
Cardiac autonomic nervous system activity in obese and never-obese young men. Obesity research. 1997 Academic Article GET IT
Times cited: 42
Autonomic nervous system activity in weight gain and weight loss. The American journal of physiology. 1995 Academic Article GET IT
Times cited: 187
The therapeutic efficacy of critical care units. Identifying subgroups of patients who benefit. Archives of internal medicine. 1989 Academic Article GET IT
Times cited: 30
Cost-effectiveness of extracorporeal shock-wave lithotripsy. Urology. 1988 Academic Article GET IT
Times cited: 10

more ...

less ...

Background

education and training

M.D., The Johns Hopkins University School of Medicine 1981
B.S., Trinity College 1977

Contact

full name

Louis J Aronne

primary email

ljaronne@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Louis J Aronne Professor of Clinical Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage